Probleme beim Einloggen

Über uns

MorphoSys AG is a biopharmaceutical company, leading in the development of innovative therapeutic antibodies. With over 100 programs MorphoSys has one of the broadest antibody pipelines in the industry. The company develops proprietary antibodies, mainly for the treatment of inflammatory diseases and cancer, and works together with its partners to create antibodies against other indications, such as Alzheimer's disease. The company was founded in 1992 and is headquartered in Martinsried, Germany. MorphoSys is listed on the Frankfurt Stock Exchange under the symbol MOR. For further information, visit